Molecular Response

Through the deal, BioDuro has acquired Molecular Response's translational oncology research platform and its biobank of viable tumor specimens.

Crown is acquiring Molecular Response's existing PDX models and 8,000 viable human tumors for model development.

NEW YORK (GenomeWeb) – Therapeutic research firm Boston Strategics and molecular diagnostic services shop Molecular Response have agreed to design and manage drug development programs together with the aim of identifying subpopulations of best responders to treatments and improving their probabil

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Transparent and Molecular Response today announced the extension of validation studies and the execution of a long-term collaboration agreement.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Gen-Probe disclosed in its annual 2011 earnings document that it has lost almost $41 million in its investment in Pacific Biosciences as of the end of 2011.

Pharmaceutical firm SuperGen will have limited access to Molecular Response's "living" cell bank of primary tumor cells, high-content imaging, and molecular characterization platforms.

The R&D deal targets oncology and cardiovascular disease.

The bank, formerly owned by Oncotech, contains more than 144,000 discrete cancer samples.

People in the News

Premium

David Ledbetter, Thomas Broudy

People in the News

Premium

RainDance taps Richard Lussier and Ingrid Choupin for sales positions; Molecular Response hires Thomas Broudy as chief scientific officer and Richard Scuderi as medical director.

New results from the NASA Twins Study indicate that the immune system may rev up when in space, the Washington Post reports.

Kelvin Droegemeier, the new science advisor, spoke at the American Association for the Advancement of Science meeting, Geekwire reports.

In PNAS this week: whole-genome assembly for the white shark, paper-based microfluidic method for detecting the malaria parasite, and more.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.